M
Martin Pelletier
Researcher at Laval University
Publications - 68
Citations - 4409
Martin Pelletier is an academic researcher from Laval University. The author has contributed to research in topics: Cytokine & Proinflammatory cytokine. The author has an hindex of 28, co-authored 64 publications receiving 3469 citations. Previous affiliations of Martin Pelletier include University of Verona & Institut national de la recherche scientifique.
Papers
More filters
Journal ArticleDOI
Reactive Oxygen Species Support the Normal Inflammatory Process and Promote Pathological Inflammation in the TNF ReceptorAssociated Periodic Syndrome (TRAPS)
Ariel C. Bulua,Martin Pelletier,Anna Simon,Ravikanth Maddipati,Heiyoung Park,Daniel L. Kastner,Richard M. Siegel +6 more
Journal ArticleDOI
TRNT1 missense mutations define an autoinflammatory disease characterized by recurrent fever, severe anemia, and b-cell immunodeficiency.
Ivona Aksentijevich,Qing Zhou,Angeliki Giannelou,Anna Sediva,Deborah L. Stone,Sergio D. Rosenzweig,Jehad H. Edwan,Martin Pelletier,Stoffels Monique,Lucie Sramkova,Amanda K. Ombrello,Karyl S. Barron,Daniel L. Kastner +12 more
TL;DR: A syndrome characterized by recurrent fever, severe anemia, gastrointestinal symptoms, and a spectrum of immunologic and neurologic symptoms in five children from four unrelated families was observed.
Journal ArticleDOI
OR9-001 - Exome sequencing in monogenic Behçet-like disease
Qing Zhou,Ronald M. Laxer,Martin Pelletier,M Ramaswamy,H-Y Wang,David T. Chin,Ahmet Gül,C Sibley,M Barat-Houari,R Siegel,DL Kastner,Ivona Aksentijevich +11 more
TL;DR: A Caucasian family with an affected mother and 2 affected daughters presented with early onset Behcet–like disease, manifesting with arthralgia/arthritis, mouth and genital ulcers, and uveitis, which is significantly ameliorated with TNF-inhibitors.
Proceedings ArticleDOI
01.16 Amp-activated protein kinase: An anti-inflammatory target for methotrexate in macrophages
TL;DR: The finding that methotrexate is able to induce AMPK activation in both human and mouse macrophages, and suppress pro-inflammatory cytokines in a manner dependent on AMPK activity raises the possibility that some anti-inflammatory effects of MTX are mediated by AMPK, and suggest that AMPK may be a target for the action of current ‘antimetabolite’ anti- inflammatory agents and a targets for the development of new anti- inflammation drugs.
Journal Article
The TNF family member TL1A promotes Th9 differentiation and Th9-mediated immunopathology (LYM3P.733)
Arianne C. Richard,Cuiyan Tan,Eric T. Hawley,Julio Gomez-Rodriguez,Ritobrata Goswami,Xiang-Ping Yang,Anthony C. Cruz,Pallavi Penumetcha,Erika T. Hayes,Martin Pelletier,Odile Gabay,Matthew C. Walsh,John R. Ferdinand,Andrea M. Keane-Myers,Yongwon Choi,John J. O'Shea,Aymen Al-Shamkhani,Mark H. Kaplan,Igal Gery,Richard M. Siegel,Françoise Meylan +20 more
TL;DR: In two models of allergic asthma, it is demonstrated that Tnfrsf25-/- mice have reduced disease severity accompanied by fewer IL-9 producing T cells in the lung, and TL1A enhances pathogenicity in Th9 transfer models of both uveitis and allergic asthma.